---
title: "Ab&B Bio-Tech Calls 2026 EGM to Overhaul Governance and Appoint New Auditor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285581318.md"
description: "Ab&B Bio-Tech CO., LTD. has scheduled its first extraordinary general meeting for May 27, 2026, in Taizhou, allowing shareholders to participate both on-site and via eVoting. Key agenda items include abolishing the supervisory committee, amending governance policies, and appointing Ms. Lui Mei Ka as an independent non-executive director, along with Prism as the new auditors. The meeting emphasizes formal governance and transparent disclosure, adhering to Hong Kong listing rules. The company, listed in Hong Kong, operates in the biotech sector and aims to enhance investor engagement and compliance with governance standards."
datetime: "2026-05-07T15:10:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285581318.md)
  - [en](https://longbridge.com/en/news/285581318.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285581318.md)
---

# Ab&B Bio-Tech Calls 2026 EGM to Overhaul Governance and Appoint New Auditor

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) just unveiled an update.

Ab&B Bio-Tech CO., LTD. JS has called its first extraordinary general meeting of 2026 for May 27 in Taizhou, with shareholders able to attend both on-site and via an eVoting portal. The meeting will be open to registered shareholders and their proxies, with detailed procedures set for registration, proxy submission, and virtual participation.

Shareholders will vote on abolishing the supervisory committee and making related amendments to the articles of association and internal governance policies. They will also consider appointing Ms. Lui Mei Ka as an independent non-executive director and Prism as the company’s auditors, changes that could reshape oversight structures and refresh the firm’s governance and audit frameworks.

The resolutions will be decided by poll in line with the company’s articles and Hong Kong listing rules, and results will be posted on the exchange and company websites. The structured voting and access arrangements underscore the company’s emphasis on formal governance processes and transparent disclosure to its investor base.

**More about Ab&B Bio-Tech CO., LTD. JS Class H**

Ab&B Bio-Tech CO., LTD. JS is a joint stock company established in the People’s Republic of China and listed in Hong Kong. The company operates in the biotech sector, with its operations based in Taizhou, Jiangsu, and is subject to Hong Kong Listing Rules and associated corporate governance requirements.

It maintains both on-site and online shareholder participation channels, reflecting a focus on accessible investor engagement and compliance with modern corporate governance standards.

**Average Trading Volume:** 952,807

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** HK$11.54B

### Related Stocks

- [02627.HK](https://longbridge.com/en/quote/02627.HK.md)

## Related News & Research

- [The Trading Awards: Voting is open until 19 May](https://longbridge.com/en/news/286793607.md)
- [Stocks in Play: Interfor Corporation](https://longbridge.com/en/news/286585579.md)
- [Triumph New Energy Sets 2025 AGM to Approve Profit Plan, Auditor and Board Changes](https://longbridge.com/en/news/287049811.md)
- [ARTRARI ONE CAPITAL CORP. REPORTS ON VOTING RESULTS FROM THE 2026 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS](https://longbridge.com/en/news/286606232.md)
- [RUSAL Sets June 25 Date for Annual Shareholder Meeting in Kaliningrad](https://longbridge.com/en/news/286588000.md)